Annovis Bio, Inc. (ANVS)
NYSE · Healthcare
Annovis Bio, Inc. Operating Income 2020–2025
Annovis Bio, Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Annovis Bio, Inc. operating income for the quarter ending March 31, 2026 was -18.0 M, a 186.70% increase year-over-year.
- Annovis Bio, Inc. operating income for the twelve months ending March 31, 2026 was -42.1 M.
- Annovis Bio, Inc. annual operating income for 2025 was -29.7 M, a 11.24% increase from 2024.
- Annovis Bio, Inc. annual operating income for 2024 was -26.7 M, a 40.72% decrease from 2023.
- Annovis Bio, Inc. annual operating income for 2023 was -45.0 M, a 76.53% increase from 2022.
- Annovis Bio, Inc. annual operating income for 2022 was -25.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Annovis Bio, Inc. Operating Income — FAQ
Annovis Bio, Inc. (ANVS) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Annovis Bio, Inc.'s operating income?
Annovis Bio, Inc. (ANVS) reported operating income of -$30M for fiscal 2025.
Where can I see ANVS's operating income history?
The chart and table above show Annovis Bio, Inc.'s operating income by year and by quarter, including the growth rate.